DES

ACC 2013.

The most relevant articles and presentations, daily report from the ACC 2013 congress, held in San Francisco, 9 – 11 march Como cada año se realizó la Convocation Ceremony en la que tuvo lugar el recambio de autoridades del American College of Cardiology. El presidente saliente Dr. William Zoghbi, dio lugar a la asunción del...

Mitraclip® year results

Original title: Residual Mitral Valve Regurgitation After Percutaneous Mitral Valve Repair with Mitraclip® System in a Risk Factor of Adverse one-Year Outcome Reference: Liliya Paranskaya et al. Catheterization and Cardiovascular Intervention 81:609-617 (2013). Currently, the gold standard for the treatment of mitral regurgitation (MR) is surgery but 20% of patients are rejected because they present a high surgical...

A worse prognosis for incomplete revascularization in both angioplasty and surgery.

Original title: The Negative Impact of Incomplete Angiographic Revascularization on Clinical Outcomes and Its Association With Total Occlusions. The SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) Trial. Reference: Vasim Farooq et al. J Am Coll Cardiol 2013;61:282–94 In patients with complex coronary artery disease who underwent coronary artery bypass surgery, (CABG), or percutaneous transluminal...

It takes more patience to implant stents.

Original title: Duration of Balloon Inflation for Optimal Stent Deployment: Five Seconds Is Not Enough. Reference: Thomas Hovasse et al. Catheterization and Cardiovascular Interventions 81:446–453 (2013). Adequate stent expansion and apposition to the vessel wall is essential to optimize the results of percutaneous transluminal coronary angioplasty (PTCA). If the above is not adequate, it increases the risk of...

XX_Tarjeton-Venezuela-2013

Jornadas Caracas 2013.

The most relevant presentations from 20° edition of SOLACI Sessions, 7th Andean and Pacific Region, held on 21, 22, 23 February 2013 in Caracas Acceda al Diario de Jornadas con los contenidos más destacados del evento.  

TAVI also for pure aortic insufficiency

Original title: Transcatheter Aortic Valve Implantation for Pure Severe Native Aortic Valve Regurgitation. Reference: David A. Roy et al. J Am Coll Cardiol 2013. Article in press. Percutaneous aortic valve replacement (TAVI) has become a standard treatment for patients with severe aortic stenosis and a high surgical risk. However for those patients who have pure aortic insufficiency, (failure...

Chronic Total Occlusion: increasingly better results and fewer complications.

Original title: Angiographic Success and Procedural Complications in Patients Undergoing Percutaneous Coronary Chronic Total Occlusion Interventions. A Weighted Meta-Analysis of 18,061 Patients From 65 Studies. Reference: Vishal G. Patel et al. J Am Coll Cardiol Intv 2013. Article in press. Chronic Total Occlusions (CTOs) are found in between 15% and 30% of patients undergoing coronary angioplasty. Successful CTOs...

Ambulatory Coronary Angiography: Is any further evidence required?

Original title: Same-Day Discharge Compared With Overnight Hospitalization After Uncomplicated Percutaneous Coronary Intervention. A Systematic Review and Meta-Analysis Reference: Eltigani Abdelaal et al. J Am Coll Cardiol Intv 2013. Article in press. Coronary angioplasty and subsequent same day discharge in selected patients can reduce costs and increase patient comfort.  Several observational studies and a few randomized studies have...

Critical limb ischemia, always try to revascularize

Original title: Endovascular Treatment for Infrainguinal Vessels in Patients With Critical Limb Ischemia : OLIVE Registry, a Prospective, Multicenter Study in Japan With 12-Month Follow-up. Reference: Osamu Iida et al. Circ Cardiovasc Interv. 2013;6:00-00 Patients with critical limb ischemia typically reveal rest pain and ischemic ulcers or gangrene. Prognosis is poor and mortality and amputation rate are elevated....

Endovascular therapy after t-PA: no additional benefit for patients with acute stroke

Original title: Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. Interventional Management of Stroke (IMS) III. Reference: Joseph P. Broderick et al. N Engl J Med 2013.DOI: 10.1056/NEJMoa1214300 Tissue plasminogen activator (t-PA; alteplase [Activase, Genentech, or Actilyse, Boehringer Ingelheim]) is the only reperfusion therapy proved useful for patients with acute ischemic stroke and its clinical efficacy...

Top